9 Results for "

scintillation proximity assay

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "scintillation proximity assay" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-10898
CAS No.: 483313-22-0
Purity:  99.93%
SB-674042 is a potent and selective non-peptide orexin OX1 receptor antagonist (Kd=5.03 nM), exhibits 100-fold selectivity for OX1 over OX2 receptors with IC50 values of 3.76 nM and 531 nM, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19949
CAS No.: 1799948-06-3
Research Areas:  

Metabolic Disease

HIF-2α-IN-1 (compound 9b) is a HIF-2α inhibitor (IC50=1.7 μM, SPA/scintillation proximity assay) .
loading...
    loading...
Cat. No.: HY-148606
CAS No.: 2839639-94-8
Target:  

STING

Research Areas:  

Cancer

STING modulator-3 is a STING inhibitor. STING modulator-3 inhibits R232 STING with an Ki value of 43.1 nM in scintillation proximity assay. STING modulator-3 has no effect on IRF-3 activation or TNF-β induction in THP-1 cells .
loading...
    loading...
Cat. No.: HY-19614
CAS No.: 939390-99-5
Target:  

CETP

Research Areas:  

Cardiovascular Disease

BMS-795311 is a potent and orally bioavailable inhibitor of cholesteryl ester transfer protein (CETP), with IC50s of 4 nM in an enzyme-based scintillation proximity assay (SPA) and 0.22 μM in a human whole plasma assay (hWPA), respectively .
loading...
    loading...
Cat. No.: HY-130264
CAS No.: 1672666-82-8
Purity:  99.93%
Research Areas:  

Cancer

HIF-2α-IN-2 is a hypoxia-inducible factors (HIF-2α) inhibitor extracted from patent WO2015035223A1, Compound 232, has an IC50 of 16 nM in scintillation proximity assay (SPA) .
loading...
    loading...
Cat. No.: HY-10555
CAS No.: 1095565-81-3
Target:  

11β-HSD

Research Areas:  

Metabolic Disease

AMG-221 is an inhibitor of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) with a Ki of 12.8 nM in vitro biochemical scintillation proximity assay (SPA) and an IC50 of 10.1 nM in cell-based assays . AMG-221 can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-128338
CAS No.: 939391-31-8
Target:  

CETP

Research Areas:  

Cardiovascular Disease

CETP-IN-3 (Compound 13) is an small molecule inhibitor of the plasma glycoprotein cholesterol ester transfer protein (CETP), elevating HDL-C through inhibition of CETP. CETP-IN-3 for the CETP inhibitory activity in the scintillation proximity (SPA) and whole plasma assay (WPA) with IC50s of 0.002 μM and 0.06 μM, respectively .
loading...
    loading...
Cat. No.: HY-183534
CAS No.: 328061-33-2
Target:  

CDK

Research Areas:  

Cancer

CDK2-IN-58 is a selective cyclin-dependent kinase 2 (CDK2) inhibitor with an IC50 of 0.21 μM. CDK2-IN-58 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-10898R
CAS No.: 483313-22-0
SB-674042 (Standard) is the analytical standard of SB-674042 (HY-10898). This product is intended for research and analytical applications. SB-674042 is a potent and selective non-peptide orexin OX1 receptor antagonist (Kd=5.03 nM), exhibits 100-fold selectivity for OX1 over OX2 receptors with IC50 values of 3.76 nM and 531 nM, respectively .
loading...
    loading...